| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And General Counsel | President
1 company
Shandell Jason B. is a President And General Counsel at Amphastar Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $3.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 26, 2016 | AMPH Amphastar Pharmaceuticals, Inc. | President And General Counsel | Sale+OE | 56,996 | $19.50 | $1,111,268.11 | -21.9% | |
| Aug 22, 2016 | AMPH Amphastar Pharmaceuticals, Inc. | President And General Counsel | Sale+OE | 10,000 | $19.95 | $199,500.00 | -4.7% | |
| Aug 17, 2016 | AMPH Amphastar Pharmaceuticals, Inc. | President And General Counsel | Sell | 5,987 | $18.86 | $112,908.83 | -2.9% | |
| Aug 11, 2016 | AMPH Amphastar Pharmaceuticals, Inc. | President | Sell | 5,636 | $18.01 | $101,482.38 | -2.6% | |
| Jun 9, 2016 | AMPH Amphastar Pharmaceuticals, Inc. | President | Sell | 9,904 | $16.43 | $162,722.72 | -4.4% | |
| May 25, 2016 | AMPH Amphastar Pharmaceuticals, Inc. | President | Sell | 1,074 | $15.60 | $16,754.40 | -0.5% |